CN1319981C - Preparation process of plantago fotal glycocide and its application in medicine - Google Patents

Abstract

The total glycosides of plantain and the pharmaceutical preparations produced by using the total glycosides of plantain as the raw materials of the medicine provide the low-level alcohol containing acid as the solvent to heat and reflux for extraction, and then purify the total glycosides of the plantain and the total glycosides of the plantain The process of preparing total glucosides of plantagosides as pharmaceutical raw materials into capsules, tablets, and granules of pharmaceutical preparations, and total glycosides of plantagosides or their pharmaceutical preparations for the treatment of chronic glomerulonephritis or/and as an immunosuppressive agent Or/and as a diuretic in the medical field.

Description

Preparation technology of total glycosides of plantain and its application in medicine

Technical Field The present invention belongs to the technical application field of traditional Chinese medicine, and is characterized in that it relates to the treatment of chronic glomerulonephritis, and/or has immunosuppressive effect, and/or has diuretic effect. Total glycosides of plantain are derived from the whole herb of the commonly used traditional Chinese medicine Plantago depressaWilld and its congeners (such as P.asiatica L., P.camtschatica Link, P.maritima L, etc.).

Background technology Chronic glomerulonephritis (chronic glomerulonephritis) is caused by a variety of diseases, through different pathogenesis, with different pathological changes, a group of diseases that originate in the glomerulus. Its clinical feature is a long course of disease, and most of them are slowly progressive. The prognosis of this disease is poor. Treatment of chronic glomerulonephritis In addition to diuretic and antihypertensive and other symptomatic treatment, the current clinical treatment of chronic glomerulonephritis drugs are mainly glucocorticoids (such as prednisone) and cytotoxic drugs (such as nitrogen mustard hydrochloride, cyclophosphine, etc.) Amide) drugs used alone or in combination, because these drugs have obvious toxic and side effects, therefore, there is an urgent need for a high-efficiency and low-toxic chronic glomerulonephritis treatment drug.

SUMMARY OF THE INVENTION The purpose of the present invention is that the total glycosides of plantain extracted from plantain and plants of the same genus can significantly reduce urine protein and diuretic effect in animal models of chronic nephritis, without obvious toxic and side effects. It can be developed into a chronic nephritis treatment agent alone or in combination with other Chinese and Western medicines.

Plantain is the dried whole herb of Plantago depressa Willd of Plantaine plant flat plantain, also known as Dangdao, which was first contained in "Sisheng Materia Medica", and its nature and flavor are sweet and cold. Return liver, kidney, lung, small intestine channel. It has the effects of clearing away heat and diuresis, cooling blood and detoxifying. Control urinary obstruction, stranguria, hematuria, edema, carbuncle sores, leukorrhea. The content of total glycosides in plantain is 0.5-6% of the medicinal materials. It is a phenylethanol glycoside compound, mainly including acteoside (acteoside), cisacteoside, isoacteoside, hydroxyacteoside, methoxyacteoside and other components, the main component of which is acteoside , accounting for 40-70% of the total glycosides.

The present invention provides a class of compounds such as structural formula I

Structural formula (I)

Structural formula (II)

The chemical composition of the total glycosides of plantago provided by the present invention is a kind of structural formula (I) as the skeleton R ₁ or hydrogen (H) or hydroxyl (OH) or methoxy (OCH ₃ ) substitution, R ₂ or is hydrogen (H) or substituted by structural formula (II), _R3 is either hydrogen (H) or substituted by structural formula (II), _R4 is rhamnosyl or a mixture substituted by hydrogen (H). The structural formula of the main component acteoside is that R ₁ and R ₂ of the structural formula (I) are substituted by hydrogen, R ₃ is substituted by the structural formula (II), and R ₄ is substituted by rhamnosyl.

Quantitative analysis of the above-mentioned compounds can be carried out by conventional methods, usually chromatography. For example HPLC method; Or use UV spectrophotometry.

As mentioned above, the total glycosides of the present invention have practical therapeutic uses such as reducing urinary protein, diuresis, and improving serum creatinine and blood urea nitrogen levels.

Detailed ways

Example 1. The preparation technology of total glycosides of plantain

Add a certain amount of acidic alcohol to plantain coarse powder, reflux and extract twice, filter, combine the two filtrates, recover the alcohol under reduced pressure to the end, centrifuge the aqueous solution to remove the precipitate, pass through the macroporous resin column, wash with water, and wash with 20~ Elute with 80% acidic alcohol, collect the eluent and recover the alcohol under reduced pressure until the end, then pass the aqueous solution through the macroporous resin column, wash with water, elute with 60-100% alcohol, collect the eluent, add activated carbon for decolorization, and filter , Recover the alcohol under reduced pressure to obtain the total glycosides of plantain in yellow-brown color.

Example 2 The diuretic effect test of total glycosides of plantain

Give rats 1 gavage administration, dosage is 60mg/Kg and 30mg/Kg, establish blank control group (distilled water) separately, each group is all given by the capacity of 25ml/Kg, intraperitoneal injection normal saline 25ml/Kg simultaneously (observation No drinking water during this period), and then put rats in metabolism cages, and put 2 rats in each cage. Record the urine output at 1, 2, 3, 4, and 6 hours. After 3 days, the animals were rotated in each group and the experiment was repeated once again. It can be seen that the urine output increased after oral administration of total psyllogen glycosides, and the 60mg/Kg group showed a diuretic effect during the whole test period from the end of the first hour to the end of the sixth hour after administration, and there was a statistical difference .

Diuretic effect of total glycosides of psyllium (n=24) group Dosemg/Kg Cumulative urine output at different times after administration (ml) (X±SD) 1h 2 hours 3 hours 4h 6 hours Control total glycosides low total glycosides high 3060 2.68±1.093.18±0.743.64±0.41 ^** 4.13±0.574.47±1.185.05±0.71 ^** 4.97±0.515.27±1.245.44±0.66 ^* 5.56±0.915.98±1.356.46±0.66 ^** 6.77±1.247.17±1.437.48±0.76 ^*

Note: T test, compared with the control group: *p<0.05, **p<0.01

Example 3 The immunomodulatory effect of total glycosides of psyllium

Method: SRBC quantitative hemolysis assay was used to observe the effect of total glycosides of psyllium on antibody production in mice.

Use BALB/C mice, females, and divide them into 5 groups evenly according to body weight; set up three dosage groups of 40, 20, and 10 mg/Kg body weight according to the dose of the drug to be tested, and give total glycosides solution of plantain orally; Oral administration of the same volume of distilled water. Dosing once a day for 9 consecutive days. Intraperitoneal injection of 15 mg/Kg cyclophosphamide was used as the positive control group, administered on the 6th to 8th day of the test, once a day. On the sixth day of administration, all mice were sensitized by intraperitoneal injection of 5% SRBC, and 96 hours after sensitization, each mouse was bled to death, and spleen was taken. Use RPMI1640 culture medium to make spleen cell suspension at 15 mg spleen weight/ml, add equal volume three spleen cell suspensions, 0.2% SRBC and 1:10 guinea pig serum to the test tube in turn, mix well, and incubate in a water bath at 37°C for 1 hour , centrifuged, and the supernatant was taken, and the absorbance was measured with a spectrophotometer, and the antibody production level was indicated by the OD value. Oral administration of 10-20 mg/Kg total psyllogen glycosides can significantly inhibit the generation of IgM antibodies in sensitized mice, and has a strong inhibitory effect on humoral immunity.

Effect of psyllid glycosides on antibody production in mice (X±SD) Dosemg/Kg number of animals Antibody hemolysis value (OD) Inhibition rate(%) Blank control CY plantain total glycosides high plantain total glycosides medium plantain total glycosides low 1520105 1210101010 1.006±0.1690.545±0.168 ^** 0.662±0.189 ^** 0.730±0.170 ^** 0.892±0.178 45.834.227.411.3

T-test *p＜0.05 **p＜0.01

Example 4 Observation of the Effect of Total Plantagosides on C-BSA Nephritis in Rats

Method 1: Add 1 mg of cationized bovine serum albumin (C-BSA), 0.5 ml of D to PBS, add 0.5 ml of incomplete adjuvant, mix thoroughly, and grind to form an emulsion. Pre-immunization was carried out by multi-point subcutaneous injection in the bilateral armpit and groin of rats. One week after pre-immunization, each rat was formally immunized. C-BSA 2.5 mg was injected into the tail vein three times a week, and the dose was increased to 4 mg/rat after four weeks until the end of the experiment.

Four weeks after the formal immunization, administration was started, once a day, for four consecutive weeks. Establish three dose groups of total psyllogen glycosides high, medium and low (respectively 40, 20, 10mg/Kg) for oral administration; cyclophosphamide (CY) 10mg/Kg for intraperitoneal injection administration is a positive control Group. The model group was given distilled water orally, and a blank control group was set up to give distilled water orally. Observing the total amount of urinary protein before the drug, 1, 2.5, and 4 weeks after administration, total psyllid glycosides 20 ~ 40mg/Kg, oral administration for four weeks, has a significant therapeutic effect on rat C-BSA nephritis , its strength of action is similar to that of intraperitoneal injection of 10mg/Kg cyclophosphamide.

24-hour urine protein change (X±SD) group Dosemg/Kg Urine protein (mg/24h) Before administration 10 days 20 days 30 days Blank model CY Siwei Shenyan Tablets Total glycosides of plantain high in total glycosides of plantain Low in total glycosides of plantain 81000502512.5 10.7±2.8(7)216.2±172.5(14)219.0±174.7(14)219.2±190.8(14)217.5±185.5(14)218.9±181.2(14)216.6±182.2(14) 13.5±3.0(7)460.6±195.4(13)293.2±131.9(12) ^* 501.5±177.5(13)427.3±213.0(14)442.7±242.0(12)431.0±220.8(12) 13.1±3.4(7)454.5±220.1(13)283.0±156.5(11) ^* 443.5±166.4(13)374.7±191.5(14)396.0±160.6(12)405.0±200.8(12) 12.4±3.4(7)427.2±178.8(12)210.9±139.1(11) ^** 380.4±159.2(12) 246.9±114.8(14) ^** 272.4±124.7(12) ^* 333.9±227.8(12)

Note: T test compared with the model group, *p<0.05 **p<0.01; the number in () is the number of animals.

Example 5 The effect of total glycosides of plantain on rabbit IgG accelerated nephrotoxic serum nephritis in mice

Under sterile conditions, the kidney cortex of the mouse was cut into pieces, ground and passed through a 200-mesh steel mesh, centrifuged at 1500rpm for 10 minutes, the sediment was taken, added Freund's complete adjuvant, and fully ground to form a uniform emulsion containing 10% kidney tissue , use this emulsion to immunize rabbits, 1ml/only, subcutaneous injection at multiple points, once a week, six times in total. For the first immunization, BCG protoplasm should be added at a concentration of 4 mg/ml emulsion. Five days after the last injection, the rabbit carotid artery was bled and centrifuged to obtain serum, which was absorbed by inactivated complement and BALB/C mouse blood cells and then centrifuged to obtain nephrotoxic serum.

Mice were first intraperitoneally injected with 0.5mg of rabbit IgG (mixed well with 0.25ml of Freund's complete adjuvant), 4 days later, the tail vein was injected with 0.08ml of nephrotoxic serum per mouse, and 5 days after the injection, the urine protein and plasma albumin of the mice were measured. content, according to its measured value, there are 6 groups evenly, model control group, positive control group, give cyclophosphamide (CY) 10mg/kg (i.p), blank control group, give distilled water (p.o), and set four doses for the administration group Group, were given total glycosides of plantain 80, 40, 20mg/kg (p.o). Continuous administration for 21 days. Urine protein was measured on the 14th day and 21st day after administration. 40-80 mg/kg of total plantain glycosides was taken orally for 3 weeks, and it had a significant therapeutic effect on rabbit IgG-accelerated nephrotoxic serum nephritis in mice, and its action intensity was similar to CY10 mg/kg (i.p); the effect of 20 mg/kg dose group weaker. Show a certain dose-effect relationship. After 22 days of bloodletting, the mouse kidneys were taken for pathological examination, routinely fixed, embedded, sectioned, stained with P.A.S and Masson's trichrome, and observed under a light microscope. Most of the animals in the model group had obvious thickening of the glomerular basement membrane, Mas- Son stained specimens showed fibrinoid necrosis in some glomerular capillaries, proliferation of cells in the wall of some glomeruli, and formation of crescents. There are protein casts in lumen. Compared with the model group, the CY group and the high-, medium-, and low-dose groups of psyllium total glycosides had milder renal lesions, and the number of protein casts in the renal tubules decreased.

Changes of urine protein in mice (X±SD) group Dose mg/kg Urinary protein (mg/dl) Before administration Dosing for 2 weeks 3 weeks Blank model CY Baoshenkang total glycosides of plantain is high total glycosides of plantain is low in total glycosides of plantain 10100804020 24.0±9.7312±76(17)306±81(16)309±80(16)312±76(17)314±74(17)309±80(17) 24.0±9.7277±44(13)202±76(12) ^* 259±69(14)194±85(14) ^** 191±91(15) ^** 221±74(14) ^* 26.0±8.4259±38(11)198±64(11) ^* 244±76(14)183±75(14) ^** 156±96(14) ^** 188±85(13) ^*

Note: T test, compared with the model group *p<0.05 **p<0.01; the numbers in ( ) represent the number of animals.

Example 6. The preparation of total glycosides of psyllium capsules

Add appropriate amount of lactose, crystalline cellulose, polyethylene glycol 3000, and sodium carboxymethyl starch to 100 g of total glycosides of plantain, dry-press granules, add appropriate amount of magnesium stearate, and divide into 1000 tablets to obtain the product. Each capsule contains acteoside 30mg.

Example 7. The preparation of total glycosides of plantain tablet

100g of total glycosides of plantain, add appropriate amount of lactose, starch, granulate with 60-80% ethanol as binder, dry, granulate, add appropriate amount of magnesium stearate, press into 1000 tablets, film-coated, each tablet Contains acteoside 30mg.

Example 8. Preparation of total glycosides of plantagosides granules

100g of total glycosides of plantain, add appropriate amount of lactose, dextrin, powdered sugar, granulate with 60-80% ethanol as binder, dry, granulate, pack into 1000 bags, each bag contains acteoside 30mg.

Claims (4)

1, the total glycosides of psyllium is used for the treatment of application in the medicine of chronic glomerulonephritis in preparation, the total glycosides of described psyllium is by being that the herb of the Chinese medicine Plantago depressa Willd of Plantago depressa Willd or its congener P.asiatica L. or P.camtschatica Link or P.maritima L. is pulverized after after acid alcohol reflux extracts twice with formal name used at school, united extraction liquid, reclaim alcohol, the centrifugal precipitation of removing, by macroporous resin column and after washing with water, the resin column acid pure wash-out of 20-80%, collect alcohol eluen, reclaim under reduced pressure alcohol, the aqueous solution is again by macroporous resin column and after washing with water, resin column 60-100% alcohol wash-out, collect alcohol eluen, add activated carbon decolorizing, the extract part that filters that back reclaim under reduced pressure alcohol and spissated method obtain based on the benzyl carbinol glycosides compounds of acteoside.

2, the application of the total glycosides of the described psyllium of claim 1 is characterized in that: the medicine that is used for the treatment of chronic glomerulonephritis is to be that raw material adds different auxiliary material with the total glycosides of psyllium, the capsule or tablet or the granule that become through certain processes.

3, the total glycosides of the described psyllium of claim 1 has application in the medicine of immunosuppressive action in preparation.

4, the total glycosides of the described psyllium of claim 1 is used for the treatment of application in the medicine of rat C-BSA ephritis or rabbit igg accelerating type mouse nephrolytic sera ephritis in preparation.